A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies
Status:
Completed
Trial end date:
2021-01-29
Target enrollment:
Participant gender:
Summary
This study is a first-in-human (FIH) study which is required to understand the PK
characteristics, MTD, and safety profile of NOV1601(CHC2014) in subjects with solid organ
malignancies.